 |
|
|
| |
Baseline ANTICIPATE score and response predicts liver outcome events in a 180 patient MASH cirrhosis cohort treated with resmetirom
|
| |
| |
EASL 2026 May 26-30 Barcelona
Naim Alkhouri,1 Rebecca Taub,2 Xiaomin Lu,2 Krishna Padmanabhan,2 Jörn M. Schattenberg,3 Mazen Noureddin4
1Summit Clinical Research, San Antonio, TX, USA; 2Madrigal Pharmaceuticals, Inc., West Conshohocken, PA, USA; 3Universitätsklinikum des Saarlandes, Homburg, Germany; 4Pinnacle Clinical Research, San Antonio, TX, USA
|
| |
|
|
|
|
|
